Understanding osteoporosis

References

• Kaplan PS. Osteoporosis. Ciba Found Symp 1983: 35(5)
   Google Scholar
• Marx JL. Osteoporosis: new help for thinning bones. Science 1980: 207(4431): 628–30
   PubMed Web of Science ®Google Scholar
• Nordin BE, Peacock M, Aaron J, et al. Osteoporosis and osteomalacia Clin Endocrinol Metab 1980: 9(1): 177–205
   Google Scholar
• Smith DM, Khalri MR, Johnston CC Jr. The loss of bone mineral with aging and its relationship to risk of fracture. J Clin Invest 1975: 56(2): 311–8
   PubMed Web of Science ®Google Scholar
• Riggs BL, Wahner HV, Dunn WL, et al. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981: 67(2): 328–35
   PubMed Web of Science ®Google Scholar
• Matkovic V, Kostial K, Simonovic I, et al. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 1979: 32(3): 540–9
   PubMed Web of Science ®Google Scholar
• Gallagher JC, Riggs BL, Eisman J, et al. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect or age and dietary calcium. J Clin Invest 1979: 64(3): 729–36
   PubMed Web of Science ®Google Scholar
• Gallagher JU, Riggs BL, Jerpbak CM, et al. The effect of age on serum Immunoreactive parathyroid hormone in normal and osteoporotic women. J Lab Clin Med 1980: 95(3): 373–85
   PubMed Web of Science ®Google Scholar
• Newcomer AD, Hodgson SF, McGill DB, et al. Lactase deficiency, prevalence in osteoporosis. Ann Intern Med 1978: 89(2): 218–20
   PubMed Web of Science ®Google Scholar
• Seeman E, Riggs BL. Dietary prevention of bone loss in the elderly. Geriatrics 1981: 36(9): 71–3, 75, 79
   PubMed Web of Science ®Google Scholar
• Shamonki IM, Frumar AM, Tataryn IV, et al. Age-related changes of calcitonin secretion in females. J Clin Endocrinol Metab 1980: 50(3): 437–9
   PubMed Web of Science ®Google Scholar
• Schindler AE, Ebert A, Fredrick E. Conversion of androstenedione to estrone by human tissue. J Clin Endocrinol Metab 1972: 35(Oct): 627–30
   PubMedGoogle Scholar
• Davidson BJ, Riggs BL, Wahner HW, et al. Endogenous Cortisol and sex steroids in patients with osteoporotic spinal fractures. Obstet Gynecol 1983: 61(3): 275–8
   PubMed Web of Science ®Google Scholar
• Manicourt DH, Orloff S, Brauman J, et al. Bone mineral content of the radius: good correlations with physicochemical determinations in iliac crest trabecular bone of normal and osteoporotic subjects. Metabolism 1981: 30(1): 57–62
   PubMed Web of Science ®Google Scholar
• Genant HK, Cann CE, Ettinger B, et al. Quantitative computed tomography of vertebral sponglosa a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982: 97(5): 699–705
   PubMed Web of Science ®Google Scholar
• Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis: its clinical features. JAMA 1941: 116(22): 2465–74
   Google Scholar
• Weiss NS, Ure CL, Ballard JH, et al. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980: 303 (21): 1195–8
   PubMed Web of Science ®Google Scholar
• Paganini-Hill A. Ross RK, Gerkins VR, et al. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981: 95(1): 28–31
   PubMed Web of Science ®Google Scholar
• Nachtigall LE, Nachtigall RH, Nachtigall RD, et al. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979: 53(3): 277–81
   PubMed Web of Science ®Google Scholar
• Heaney RP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin Med 1978: 92(6): 964–70
   PubMed Web of Science ®Google Scholar
• Whitehead MI, Townsend PT, Pryse-Davies J, et al. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981: 305(27): 1599–605
   PubMed Web of Science ®Google Scholar
• Wahl P, Walden C, Knopp R, et al. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med 1983: 308(15): 862–7
   PubMed Web of Science ®Google Scholar
• Mallette LE. Osteoporosis: approaching treatment with optimism. Postgrad Med 1982: 72(5): 271–8
   PubMed Web of Science ®Google Scholar
• Moller PF, Gudjonnson SV. Massive fluorosis of bones and ligaments. Acta Radiol Scand 1932: 13(3): 269–94
   Google Scholar
• Grandjean P. Occupational fluorosis through 50 years: clinical and epidemiological experiences. Am J Industr Med 1982: 3(2): 227–36
   PubMedGoogle Scholar
• Bernstein DS, Sadowsky N, Hegsted DM, et al. Prevalence of osteoporosis in high-and low-fluoride areas in North Dakota JAMA 1966: 198(Oct 31): 449–504
   Google Scholar
• Alhava EM, Olkkonen H, Kauranen P, et al. The effect of drinking water fluoridation on the fluoride content, strength and mineral density of human bone. Acta Orthop Scand 1980: 51(3): 413–20
   PubMedGoogle Scholar
• Ream LJ. The effects of short-term fluoride Ingestion on bone formation and resorption in the rat femur. Cell Tissue Res 1981: 221(2): 421–30
   PubMed Web of Science ®Google Scholar
• Compston JE, Chadha S, Merrett AL. Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D. Br Med J 1980: 281(6245): 910–1
   PubMedGoogle Scholar
• Rich C, Ensinck J. Effect of sodium fluoride on calcium metabolism of human beings. Nature 1961: 191(Jul 8): 184–5
   PubMed Web of Science ®Google Scholar
• Grove O, Halver B. Relief of osteoporotic backache with fluoride, calcium and calciferol. Acta Med Scand 1981: 209(6): 469–71
   PubMedGoogle Scholar
• Aloia JF, Zanzi I, Vaswani A, et al. Combination therapy for osteoporosis with estrogen, fluoride, and calcium. J Am Geriatr Soc 1982: 30(1): 13–7
   PubMed Web of Science ®Google Scholar
• Jowsey J, Riggs BL, Kelly PJ, et al. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 1972: 53(Jul): 43–9
   PubMed Web of Science ®Google Scholar
• Briançon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am 1981: 12(3): 629–48
   PubMed Web of Science ®Google Scholar
• Harrison JE, McNeill KG, Sturtridge WC, et al. Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton. J Clin Endocrinol Metab 1981: 52(4): 751–8
   PubMed Web of Science ®Google Scholar
• Riggs BL, Seeman E, Hodgson SF, et al. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: comparison with conventional therapy. N Engl J Med 1982: 306(8): 446–50
   PubMed Web of Science ®Google Scholar
• Vigorita VJ, Suda MK. The microscopic morphology of fluoride-induced bone. Clin Orthop 1983: 177: 274–82
   PubMed Web of Science ®Google Scholar
• Spencer H, Kramer L, Osis D, et al. Effect of calcium, phosphorus, magnesium, and aluminum on fluoride metabolism in man. Ann NY Acad Sci 1980: 355: 181–94
   PubMedGoogle Scholar
• Bikle DD. Fluoride treatment of osteoporosis: a new look at an old drug. (Editorial) Ann Intern Med 1983: 98(6): 1013–5
   PubMed Web of Science ®Google Scholar
• Transbøl I, Christensen MS, Jensen GF, et al. Thiazide for the postponement of postmenopausal bone loss. Metabolism 1982: 31(4): 383–6
   PubMed Web of Science ®Google Scholar
• Chestnut CH 3d, Nelp WB, Baylink DJ, et al. Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass. Metabolism 1977: 26(3): 267–77
   PubMed Web of Science ®Google Scholar